CohBar's Alzheimer's Grant to Probe Mitochondrial Function
By Catherine Shaffer
Thursday, March 7, 2013
A grant by the Alzheimer's Drug Discovery Foundation (ADDF) will support research into the role of mitochondria in Alzheimer's disease. The award of $205,260 will go to CohBar Inc., of Pasadena, Calif., which is developing a mitochondrial peptide designed to protect neurons from dying by improving mitochondrial function, reducing inflammation, increasing insulin sensitivity and decreasing oxidative stress.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.